Ahead of an approval filing, the drugmaker is amping up a fight against sellers who claim to offer versions of its highly anticipated “triple-G” weight loss medicine.
Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
Shareholders angry over the stock’s decline are alleging fraud with a complaint that has no merit, the payment processor said in its response.

The New York City Council is investigating four prediction markets for alleged deceptive marketing practices and targeting minors, opening a new front in the bitter, state-by-state legal war over prediction-market regulation. City Council Speaker Julie Menin sent letters to Polymarket, Kalshi, Coinbase and Gemini Titan, all of which have a presence in New York City, on Aug. 11 seeking answers about how the companies comply with consumer protection laws. In a letter addressed to Polymarket founder and Chief Executive Shayne Coplan, Menin asked for details about Polymarket promotional videos that appeared to depict fake trades and promoted insider trading on social media.

An appeals court ruled more than 3,000 lawsuits against Meta, Google, TikTok and Snapchat over addictive design claims targeting youth can proceed.

Meta Platforms (NasdaqGS:META) is pushing to open source superintelligent AI models and has launched Muse Glimmer as part of this effort. Mark Zuckerberg outlined a plan to make advanced AI widely accessible rather than keeping it locked behind premium services. Meta announced a US$1b fund aimed at supporting communities located near its data centers. The 9th Circuit allowed thousands of social media addiction lawsuits against Meta to proceed, increasing legal and regulatory pressure on the...
The safety action covers certain Model 3 and Model Y vehicles, while regulators have not finalized a remedy.
According to the National Highway Traffic Safety Administration, the low-beam headlights could be excessively bright, which in turn could make it harder for oncoming motorists to see clearly, increasing the risk of a collision.
The automaker is recalling more than 20,000 vehicles over headlights that may be too bright for oncoming drivers.
The company is fighting to protect itself from liability in multiple cases of social media addiction and a potentially crushing wave of payouts.
Platforms like Meta, TikTok, Snapchat, and Google are facing a long road of litigation.
The appeals court ruled Section 230 provides a liability defense, not immunity, making Meta's appeal premature
By Diana Novak Jones Aug 10 (Reuters) - A U.S. appeals court on Monday allowed thousands of lawsuits to move forward against Meta Platforms, Alphabet's Google, ByteDance's TikTok, and other social
mFLUSIVA is now the first and only mRNA standalone seasonal influenza vaccine on the market, marking a major advancement for the field.
Johnson & Johnson (NYSE:JNJ) has officially entered the U.S. soft-tissue robotic surgery market after receiving FDA De Novo authorization for its OTTAVA robotic surgical system. The authorization represents an important milestone for J&J’s MedTech ambitions, but the company is entering a market in which Intuitive Surgical (NASDAQ:ISRG) already has an extensive installed base, established surgeon […]
Firefox developer Mozilla is warning that it could be forced to "exit the browser and browser engine markets" if it can no longer receive payment from Google for distributing its search engine.
Dismissal removes one legal challenge involving compounded alternatives while Novo confronts intensifying commercial competition in obesity treatments.
Johnson & Johnson (NYSE: JNJ) agreed to a US$5.5b settlement to resolve tens of thousands of talc baby powder lawsuits. The deal ends decades of litigation over alleged health risks tied to the company’s talc-based products. The settlement follows years of high profile trials and failed bankruptcy attempts related to the talc claims. This resolution removes a long running legal overhang and brings more clarity for Johnson & Johnson investors. Consider broadening your research to other large...
Boston Scientific (NYSE: BSX) has initiated multiple product recalls covering cardiac ablation generators and vascular access sheaths due to labeling discrepancies and air embolism risks. The recalls affect a broad mix of devices used in cardiac and vascular procedures across several international markets. Regulators and hospitals are assessing the implications for device safety protocols, clinical workflows, and future use of the impacted products. Product safety questions can prompt...
A Texas judge dismissed claims that the drugmakers illegally blocked access to compounded weight-loss drugs.
Apple (NasdaqGS:AAPL) has filed a lawsuit against OpenAI alleging misappropriation of confidential AI and hardware technology trade secrets. The complaint seeks a preliminary injunction that Apple says is needed to prevent irreparable harm to its core AI and device development work. The case could bring internal details of Apple's AI research, product security practices, and development processes into public view. Legal and competitive risks around AI intellectual property are back in focus...
Rackspace Technology stock has delivered a very strong run year to date, yet its valuation checks still point to shares screening on the cheap side rather than fully pricing in that move. Year to date the share price is up 394.7%, which puts a lot more weight on whether current expectations for the business can hold. Investor focus is split between the potential upside from Rackspace Technology’s push into enterprise and sovereign AI infrastructure and the valuation risk tied to multiple...
Alibaba Group Holding (NYSE:BABA) is back in the spotlight after Rosen Law Firm filed a class action lawsuit covering investors who bought the stock between June 26, 2025 and June 24, 2026. See our latest analysis for Alibaba Group Holding. Recent AI announcements, including the Qwen3.8 Max model and reports of potential automotive use cases, have helped Alibaba Group Holding’s 30 day share price return reach 29.21%. However, the year to date share price return remains down 18.58% and the 5...
Moderna has secured FDA approval for its flu vaccine mFLUSIVA. But does that warrant buying MRNA shares today? Let’s find out!
Bloom Energy (BE) is back in focus after a class action lawsuit was filed on July 31, 2026, following a short seller report on its scandium sourcing and a same day stock price decline. See our latest analysis for Bloom Energy. Recent events around Bloom Energy have played out against a backdrop of sharp share price swings, with the stock posting a 7 day share price return of 43.10% but a 30 day share price return down 20.58%. Despite this volatility, the year to date share price return of...
Moderna (NASDAQ:MRNA) announced on Thursday that the U. S.
Apple Inc. has asked a U.S. judge to issue a preliminary injunction preventing two former employees and OpenAI from accessing, using, or disclosing alleged confidential information while its trade secrets lawsuit proceeds. Apple asked the court to require former employees...
The Food and Drug Administration approved Moderna’s mRNA-based flu vaccine for adults ages 50 and older, clearing the first shot of its kind after a review process that nearly collapsed in February. The vaccine, called mFlusiva, uses the same mRNA technology as Moderna’s Covid-19 shots. It could reach pharmacies in time for the coming flu season, which typically starts in the fall.
Lululemon athletica (NasdaqGS:LULU) is facing a consumer lawsuit in California that challenges its use of reference prices on discounted items. The complaint alleges that Lululemon used former prices that did not reflect actual recent selling prices, creating the appearance of larger discounts. The case adds to broader legal scrutiny of how major retailers communicate pricing and promotions to shoppers. Lululemon athletica has built its brand around premium athletic and leisure apparel,...
Philip Morris International (NYSE:PM) is back in focus after Brazil’s landmark public health lawsuit moved a step closer to a liability ruling, putting long running legal risks alongside fresh investment and earnings data. See our latest analysis for Philip Morris International. The share price of Philip Morris International has pulled back in the past week with a 7 day share price return of 6.6% in the red, even after a 90 day share price return of 9.6% and a 1 year total shareholder return...
Food safety scares and recalls have pressured restaurant and grocery stocks in 2026, raising concerns about costs, supply chains, and brand trust.